Arcellx to participate at the td cowen 44th annual health care conference

Redwood city, calif. , feb. 29, 2024 /prnewswire/ -- arcellx, inc. (nasdaq: aclx), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management will participate in a fireside chat at the td cowen 44th annual health care conference on wednesday, march 6, at 2:50 p.m.
ACLX Ratings Summary
ACLX Quant Ranking